Severgnini Achille G. → Royalty Pharma plc RPRX

Stake: — Shares: 21,366,927 Class: Class A Ordinary Shares, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 32/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Active Schedule 13D filer baseline
Held by 1 tracked 13F institutional manager
Moderate short days-to-cover (4.3 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 4.28

12,843,101 shares short · -0.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $20.65M

Point72 Asset Mgmt

Post-Filing Returns · since 2026-06-12 on RPRX

+1 day

0.0%

+5 days

0.0%

+30 days

-2.3%

+60 days

—

+90 days

—

+180 days

—

Anchor price 57.80 on closest trading day on/after 2026-06-12. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Royalty Pharma plc

Filed	Form	Filer	Stake	Shares
2026-08-17	SCHEDULE 13D/A	Legorreta Pablo G.	—	101,785,843	view →
2025-02-21	SCHEDULE	Severgnini Achille G.	8.30%	36,001,535	view →
2022-10-04	SC	Giuliani Mario Germano	—	—	view →

Other Filings by Severgnini Achille G.

Filed	Form	Issuer	Stake	Shares
2025-02-21	SCHEDULE	Royalty Pharma plc RPRX	8.30%	36,001,535	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →